UB Paderborn / Katalog / Suche / in CDI

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

The Lancet (British edition), 2017-03, Vol.389 (10073), p.1025-1034

2017

Link zum Volltext

Verfügbarkeit prüfen

Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs

Thrombosis and haemostasis, 2019-01, Vol.119 (1), p.149

2019

Link zum Volltext

Verfügbarkeit prüfen

Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention

Annals of internal medicine, 2017-07, Vol.167 (1), p.17

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparing methods for estimating patient‐specific treatment effects in individual patient data meta‐analysis

Statistics in medicine, 2021-03, Vol.40 (6), p.1553-1573

2021

Link zum Volltext

Verfügbarkeit prüfen

Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting

JACC. Cardiovascular interventions, 2012-03, Vol.5 (3), p.268-277

2012

Link zum Volltext

Verfügbarkeit prüfen

Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experience

PloS one, 2019-02, Vol.14 (2), p.e0209502-e0209502

2019

Link zum Volltext

Verfügbarkeit prüfen

Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification

PloS one, 2022-02, Vol.17 (2), p.e0263180-e0263180

2022

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment With P2Y12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified

Circulation (New York, N.Y.), 2014-11, Vol.130 (21), p.1891-1903

Valgimigli, Marco

2014

Link zum Volltext

Verfügbarkeit prüfen

The MATRIX trial - Author's reply

The Lancet (British edition), 2019-05, Vol.393 (10183), p.1803-1804

Valgimigli, Marco

2019

Link zum Volltext

Verfügbarkeit prüfen

"Tailored" antiplatelet bridging therapy with cangrelor: moving toward personalized medicine

Platelets (Edinburgh), 2022-07, Vol.33 (5), p.687-691

2022

Link zum Volltext

Verfügbarkeit prüfen

DAPT Duration After Drug-Eluting Stent Implantation

JACC. Cardiovascular interventions, 2017-06, Vol.10 (12), p.1211-1214

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration

Journal of the American College of Cardiology, 2015-09, Vol.66 (10), p.1203-1204

2015

Link zum Volltext

Verfügbarkeit prüfen

Shifting the Focus to Recurrences

JACC. Cardiovascular interventions, 2014-10, Vol.7 (10), p.1114-1116

Valgimigli, Marco, MD, PhD

2014

Link zum Volltext

Verfügbarkeit prüfen

Bivalirudin in Current Practice

JACC. Cardiovascular interventions, 2016-07, Vol.9 (13), p.1321-1323

2016

Link zum Volltext

Verfügbarkeit prüfen

Differential impact of fentanyl and morphine doses on ticagrelor-induced platelet inhibition in ST-segment elevation myocardial infarction: a subgroup analysis from the PERSEUS randomized trial

Frontiers in cardiovascular medicine, 2024, Vol.11, p.1324641-1324641

2024

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic Therapy After Left Atrial Appendage Occlusion

JACC. Cardiovascular interventions, 2022-01, Vol.15 (1), p.113-114

2022

Link zum Volltext

Verfügbarkeit prüfen

Distal Transradial Access for Coronary Procedures

JACC. Cardiovascular interventions, 2022-01, Vol.15 (1), p.33-38

2022

Link zum Volltext

Verfügbarkeit prüfen

Ticagrelor in patients with diabetes and previous PCI

The Lancet (British edition), 2019-09, Vol.394 (10204), p.1118-1120

2019

Link zum Volltext

Verfügbarkeit prüfen

Large-Bore Radial Access for Complex PCI

JACC. Cardiovascular interventions, 2021-06, Vol.14 (12), p.1304-1307

2021

Link zum Volltext

Verfügbarkeit prüfen

Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis

Journal of the American College of Cardiology, 2014-02, Vol.63 (6), p.506-512

2014

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment With P2Y 12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified

Circulation (New York, N.Y.), 2014-11, Vol.130 (21), p.1891-1903

Valgimigli, Marco

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention

Comparing methods for estimating patient‐specific treatment effects in individual patient data meta‐analysis

Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary Stenting

Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experience

Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification

Pretreatment With P2Y12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified

The MATRIX trial - Author's reply

"Tailored" antiplatelet bridging therapy with cangrelor: moving toward personalized medicine

DAPT Duration After Drug-Eluting Stent Implantation

Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration

Shifting the Focus to Recurrences

Bivalirudin in Current Practice

Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Differential impact of fentanyl and morphine doses on ticagrelor-induced platelet inhibition in ST-segment elevation myocardial infarction: a subgroup analysis from the PERSEUS randomized trial

Antithrombotic Therapy After Left Atrial Appendage Occlusion

Distal Transradial Access for Coronary Procedures

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial

Ticagrelor in patients with diabetes and previous PCI

Large-Bore Radial Access for Complex PCI

Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis

Pretreatment With P2Y 12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified

The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome

Aktive Filter

Suchergebnisse filtern